BRIEF-Allergan CEO says investors must question Valeant's "mishmash" financial reporting
June 10 (Reuters) - Allergan: * Allergan CEO says he's an "endurance player," prepared for long
battle with Valeant * Allergan CEO says first priority among its shareholders is for company to
make strategic acquisitions * Allergan CEO says Valeant stands alone in industry by failure to disclose
product sales, instead has "mishmash" of reporting buckets * Allergan CEO says company, investors need to question value of Valeant stock
© Thomson Reuters 2017 All rights reserved.